Publication | Closed Access

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies

InfertilityHormonal ContraceptiveFertilityBreast Cancer PatientsControlled Ovarian HyperstimulationReproductive HealthGynecologyBreast CancerFertility TrackingPublic HealthMedicineRadiation OncologyOvarian HormoneFertility PreservationEndocrine-related CancerOvarian CancerTamoxifen Co-administration